These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 20472479
1. Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities. Bustamante JJ, Grigorian AL, Muñoz J, Aguilar RM, Treviño LR, Martinez AO, Haro LS. Growth Horm IGF Res; 2010 Aug; 20(4):298-304. PubMed ID: 20472479 [Abstract] [Full Text] [Related]
9. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the effect on the human prolactin receptor. Tsunekawa B, Wada M, Ikeda M, Uchida H, Naito N, Honjo M. Endocrinology; 1999 Sep; 140(9):3909-18. PubMed ID: 10465259 [Abstract] [Full Text] [Related]
10. The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells. Hansen BS, Hjorth S, Welinder BS, Skriver L, De Meyts P. Endocrinology; 1993 Dec; 133(6):2809-17. PubMed ID: 8243308 [Abstract] [Full Text] [Related]
12. Extracellular domain of prolactin receptor from bovine mammary gland: expression in Escherichia coli, purification and characterization of its interaction with lactogenic hormones. Tchelet A, Staten NR, Creely DP, Krivi GG, Gertler A. J Endocrinol; 1995 Mar; 144(3):393-403. PubMed ID: 7738463 [Abstract] [Full Text] [Related]
13. Analysis of binding properties between 20 kDa human growth hormone (hGH) and hGH receptor (hGHR): the binding affinity for hGHR extracellular domain and mode of receptor dimerization. Uchida H, Banba S, Wada M, Matsumoto K, Ikeda M, Naito N, Tanaka E, Honjo M. J Mol Endocrinol; 1999 Dec; 23(3):347-53. PubMed ID: 10601980 [Abstract] [Full Text] [Related]
14. Site-directed mutagenesis of recombinant bovine placental lactogen at lysine-73 leads to selective attenuation of its somatogenic activity. Helman D, Staten NR, Byatt J, Grosclaude J, McKinnie RE, Djiane J, Gertler A. Endocrinology; 1997 Oct; 138(10):4069-80. PubMed ID: 9322914 [Abstract] [Full Text] [Related]
17. Indication of different lactogen and somatogen binding sites in the human growth hormone molecule as probed with monoclonal antibodies. Strasburger CJ, Binder L, Elberg G, Cohen-Chapnik N, Kohen F, Gertler A. Mol Cell Endocrinol; 1989 Nov; 67(1):55-62. PubMed ID: 2482210 [Abstract] [Full Text] [Related]
18. Mitogenic and binding properties of monoclonal antibodies to the prolactin receptor in Nb2 rat lymphoma cells. Selective enhancement by anti-mouse IgG. Elberg G, Kelly PA, Djiane J, Binder L, Gertler A. J Biol Chem; 1990 Sep 05; 265(25):14770-6. PubMed ID: 2394695 [Abstract] [Full Text] [Related]
19. Human growth hormone-variant demonstrates a receptor binding profile distinct from that of normal pituitary growth hormone. Ray J, Okamura H, Kelly PA, Cooke NE, Liebhaber SA. J Biol Chem; 1990 May 15; 265(14):7939-44. PubMed ID: 2335510 [Abstract] [Full Text] [Related]
20. Ovine placental lactogen and human growth hormone bind to different regions of the same receptors. Longhi SA, Wolfenstein-Todel C, Gómez KA, Miranda ME, Retegui LA. Growth Horm IGF Res; 1999 Jun 15; 9(3):157-64. PubMed ID: 10502451 [Abstract] [Full Text] [Related] Page: [Next] [New Search]